| __timestamp | Supernus Pharmaceuticals, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72471000 | 1643000000 |
| Thursday, January 1, 2015 | 89204000 | 1532000000 |
| Friday, January 1, 2016 | 106010000 | 1364000000 |
| Sunday, January 1, 2017 | 137905000 | 1334000000 |
| Monday, January 1, 2018 | 159888000 | 1484000000 |
| Tuesday, January 1, 2019 | 158425000 | 1638000000 |
| Wednesday, January 1, 2020 | 200677000 | 1726000000 |
| Friday, January 1, 2021 | 304759000 | 2001000000 |
| Saturday, January 1, 2022 | 377221000 | 2009000000 |
| Sunday, January 1, 2023 | 336361000 | 2151000000 |
| Monday, January 1, 2024 | 2318000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Zoetis Inc. and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Zoetis consistently outpaced Supernus in SG&A spending, with expenses peaking at approximately $2.15 billion in 2023, marking a 30% increase from 2014. In contrast, Supernus saw a more dramatic rise, with expenses surging by over 360%, reaching around $377 million in 2022. This stark difference highlights Zoetis's established market presence and operational scale, while Supernus's rapid growth reflects its aggressive expansion strategy. As the pharmaceutical landscape continues to shift, these financial insights offer a glimpse into the strategic priorities and market positioning of these two industry players.
Cost Management Insights: SG&A Expenses for Vertex Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Zoetis Inc. vs Bio-Techne Corporation
Comparing SG&A Expenses: Zoetis Inc. vs Veracyte, Inc. Trends and Insights
Breaking Down SG&A Expenses: Zoetis Inc. vs BioCryst Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Incyte Corporation and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: CRISPR Therapeutics AG vs Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Bausch Health Companies Inc. or Supernus Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Vericel Corporation and Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Wave Life Sciences Ltd.
Supernus Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: SG&A Expense Trends